10,000 results · 197ms · Sources: EU EUDAMED, US FDA

Cytokeratin 5/14 (QR027 & QR057)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD20 (QR094)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD20 (QR094)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD20 (QR094)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD20 (QR094)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM (QR039)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM (QR039)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM (QR039)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM (QR039)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM (QR039)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD171/L1CAM (QR039)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD138 (QR102)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

CD103 (QR081)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market